O'Callaghan Dermot S, Gaine Sean P
Department of Respiratory Medicine, Mater Misericordiae University Hospital, University College Dublin, Eccles Street, Dublin 7, Ireland.
Clin Chest Med. 2007 Mar;28(1):169-85, ix. doi: 10.1016/j.ccm.2006.11.011.
This review assesses the available evidence supporting the use of drug combinations for the management of the various forms of pulmonary arterial hypertension (PAH). Ongoing and forthcoming randomized trials evaluating this strategy are also highlighted. Furthermore, new types of agents to treat PAH in the future are explored.